Inhibition of angiogenin induced corneal angiogenesis by a Farnesyl transferase inhibitor.

被引：0
|
作者：
Park, YH [1 ]
Chung, SK [1 ]
Lee, JY [1 ]
Joo, CK [1 ]
Baek, NH [1 ]
Kim, JH [1 ]
机构：
[1] Catholic Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2000年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4426B373
引用
收藏
页码：S833 / S833
页数：1
相关论文
共 50 条
  • [1] Inhibition of vascular endothelial growth factor induced corneal angiogenesis by a farnesyl transferase inhibitors
    Jung, CS
    Lee, JY
    Chung, SK
    Joo, CK
    Baek, NH
    Kim, JH
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S98 - S98
  • [2] Analogues of cylindrol A, a novel farnesyl protein transferase inhibitor.
    Cermak, SC
    Wilson, JM
    Wiemer, DF
    Hohl, RJ
    LewisTibesar, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 55 - MEDI
  • [3] Effect of food on the pharmacokinetics of lonafarnib, a farnesyl protein transferase inhibitor.
    Zhu, Y
    Statkevich, P
    Cutler, DL
    Pember, L
    Curtis, D
    Batra, VK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P82 - P82
  • [4] Pharmacokinetics (PK) of lonafarnib (L), a farnesyl protein transferase inhibitor.
    Zhu, Y
    Statkevich, P
    Cutler, DL
    Calzetta, A
    Curtis, D
    Batra, VK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P59 - P59
  • [5] Neomycin is an angiogenesis inhibitor.
    Hu, GF
    FASEB JOURNAL, 1999, 13 (05): : A705 - A705
  • [6] Synergistic suppression of metastatic phenotype in vitro and metastasis in vivo by a bisphosphonate plus a farnesyl transferase inhibitor.
    Andela, V
    Schwarz, E
    O'Keefe, R
    Rosenblatt, J
    Puzas, E
    Rosier, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S192 - S192
  • [7] Synthesis of A-228839.25, farnesyl transferese inhibitor.
    Premchandran, RH
    Bhagavatula, L
    Mcdermott, T
    Bailey, AE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U56 - U56
  • [8] Inhibition of corneal neovasculization by the topical use of the Ras farnesyltransferase inhibitor.
    Sonoda, KH
    Sakamoto, T
    Yoshikawa, H
    Ishibashi, T
    Inomata, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 3648 - 3648
  • [9] Synthesis and metabolism of two isotopomers of a C-14 labeled farnesyl-protein transferase inhibitor.
    Elmore, CS
    Dean, DC
    Marks, TM
    Braun, MP
    Yu, NX
    Zhang, Y
    Raab, CE
    Singh, R
    Jin, LX
    Melillo, DG
    Dinsmore, CJ
    Williams, TM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U29 - U29
  • [10] The effect of a novel CAAX peptidomimetic farnesyl transferase inhibitor on angiogenesis in vitro and in vivo.
    Gu, WZ
    Tahir, SK
    Zhang, HC
    OConnor, SJ
    Ng, SC
    Rosenberg, SH
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 1058 - 1058
12345